Biohaven (BHVN) Payables (2021 - 2026)

Biohaven has disclosed Payables across 6 years of filings, most recently posting $10.4 million for Q1 2026.

• Payables for Q1 2026 came in at $10.4 million, down 45.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.4 million (down 45.55% YoY), and the FY2025 annual result was $11.6 million, down 35.42% from the prior year.
• Payables came in at $10.4 million for Q1 2026 at Biohaven, down from $11.6 million in the prior quarter.
• In the past five years, Payables ranged from a high of $36.4 million in Q1 2024 to a low of $4.7 million in Q3 2022.
• The 5-year median for Payables is $15.6 million (2023), against an average of $15.8 million.
• Across the five-year window, Payables surged 151.69% in 2024 and sank 47.39% in 2025, its largest moves.
• Biohaven's Payables stood at $10.7 million in 2022, then surged by 45.54% to $15.6 million in 2023, then rose by 15.74% to $18.0 million in 2024, then plunged by 35.42% to $11.6 million in 2025, then dropped by 10.49% to $10.4 million in 2026.
• The last three Payables figures came in at $10.4 million (Q1 2026), $11.6 million (Q4 2025), and $17.5 million (Q3 2025), per Business Quant data.